Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

PharmaSGP Holding SE, DE000A2P4LJ5

PharmaSGP Holding SE, DE000A2P4LJ5

22.06.2020 - 16:33:08

PharmaSGP Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer Name: PharmaSGP Holding SE Street: Lochhamer Schlag 21 Postal code: 82166 City: GräfelfingGermany Legal Entity Identifier (LEI): 3912005CZ12PVVCIPT91 2. Reason for notification   Acquisition/disposal of shares with voting rights   Acquisition/disposal of instruments   Change of breakdown of voting rights X Other reason:First-time admission of the shares for trading on an organised market. 3. Details of person subject to the notification obligation Natural person (first name, surname): Dr. Clemens FischerDate of birth: 28 May 1975 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.FUTRUE GmbH, MVH Beteiligungs- und Beratungs-GmbH 5. Date on which threshold was crossed or reached: 18 Jun 2020 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG New 100.00 % 0.00 % 100.00 % 12,000,000 Previous notification n/a % n/a % n/a % / 7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) ISIN Absolute In %   Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) DE000A2P4LJ5 0 12,000,000 0.00 % 100.00 % Total 12,000,000 100.00 % b.1. Instruments according to Sec. 38 (1) no. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % 0 0.00 %     Total 0 0.00 % b.2. Instruments according to Sec. 38 (1) no. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % 0 0.00 %       Total 0 0.00 % 8. Information in relation to the person subject to the notification obligation  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more) Dr. Clemens Fischer % % % FUTRUE GmbH 100.00 % % 100.00 % 9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:Proportion of voting rights Proportion of instruments Total of both % % % 10. Other explanatory remarks:On the basis of a voting trust agreement between FUTRUE GmbH and MVH Beteiligungs- und Beratungs-GmbH, FUTRUE GmbH and MVH Beteiligungs- und Beratungs-GmbH mutually allocate the voting rights with regard to all shares they hold in PharmaSGP Holding SE.  Date19 Jun 2020

22.06.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: PharmaSGP Holding SE Lochhamer Schlag 21 82166 Gräfelfing

Germany Internet: https://sgp-pharma.com   End of News DGAP News Service

1074481  22.06.2020 

@ dgap.de